Page last updated: 2024-11-05

phorone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phorone: an industrial solvent; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10438
CHEMBL ID2766015
CHEBI ID35572
SCHEMBL ID157728
MeSH IDM0070360

Synonyms (55)

Synonym
AKOS015841777
2,5-heptadien-4-one, 2,6-dimethyl-
s-diisopropylidene acetone
phorone
nsc38718
wln: 1y1&u1v1uy1&1
diisobutenyl ketone
sym-diisopropylidene acetone
foron
diisopropylidene acetone
504-20-1
2,5-heptadien-4-one
phoron
nsc-38718
2,6-dimethylhepta-2,5-dien-4-one
CHEBI:35572 ,
2,6-dimethyl-2,5-heptadiene-4-one
ai3-00047
2,6-dimethyl-2,5-heptadien-4-one
brn 1699751
ccris 4350
phoron [german]
einecs 207-986-3
nsc 38718
diisopropylideneacetone
nsc-403517
nsc403517
2,6-dimethyl-2,5-heptadien-4-one, 95%
inchi=1/c9h14o/c1-7(2)5-9(10)6-8(3)4/h5-6h,1-4h
NCGC00248921-01
dtxsid1021584 ,
dtxcid101584
NCGC00258649-01
tox21_201097
cas-504-20-1
CHEMBL2766015
unii-8f20oei0mv
4-01-00-03564 (beilstein handbook reference)
8f20oei0mv ,
phorone [mi]
SCHEMBL157728
mfcd00008901
SY026937
FT-0698485
2,6-dimethyl-hepta-2,5-dien-4-one
GS-4453
CS-W018571
STL554155
Q612199
dimethylsuberate
F12420
EN300-125149
AMY13323
BBL100361
A871568

Research Excerpts

Actions

ExcerptReferenceRelevance
"Phorone was able to produce the changes in these parameters in a dose-dependent manner."( Effects of phorone (diisopropylidene acetone), a glutathione (GSH) depletor, on hepatic enzymes involved in drug and heme metabolism in rats: evidence that phorone is a potent inducer of heme oxygenase.
Kuroiwa, Y; Numazawa, S; Oguro, T; Yoshida, T, 1987
)
1.38

Treatment

Pretreatment with phorone (300 mg/kg intrapentoneally [ip]), which reduced hepatic GSH by 90%, did not cause any difference in intracellular ROS generation compared with the control livers. Phorone treatment attenuated ANIT-induced elevations in serum total bilirubin concentration and AST activity.

ExcerptReferenceRelevance
"Phorone treatment (1.65 mM) resulted in depletion of intracellular glutathione in all three groups to approximately 20% of that in untreated hepatocytes."( Toxicity studies in isolated hepatocytes from selenium-deficient rats and vitamin E-deficient rats.
Burk, RF; Hill, KE, 1984
)
0.99
"Phorone treatment did not increase the AFB1-induced mutation frequency in the lung and intestine."( Aflatoxin B1 induced lacI mutation in liver and kidney of transgenic mice C57BL/6N: effect of phorone.
Autrup, H; Jensen, O; Jørgensen, EC, 1996
)
1.23
"Phorone treatment attenuated ANIT-induced elevations in serum total bilirubin concentration and AST activity."( Protection against alpha-naphthylisothiocyanate-induced liver injury by decreased hepatic non-protein sulfhydryl content.
Dahm, LJ; Roth, RA, 1991
)
1
"Pretreatment with phorone, a glutathione S-transferase substrate, depleted cellular glutathione and decreased nitrite production from GTN."( Metabolism of nitroglycerin by smooth muscle cells. Involvement of glutathione and glutathione S-transferase.
Burk, RF; Hill, KE; Hoover, RL; Hunt, RW; Jones, R, 1992
)
0.61
"Pretreatment with phorone (300 mg/kg intrapentoneally [ip]), which reduced hepatic GSH by 90%, did not cause any difference in intracellular ROS generation compared with the control livers."( Glutathione and ischemia-reperfusion injury in the perfused rat liver.
Chance, B; Kumar, C; Lee, HC; Okuda, M, 1992
)
0.61
"Pretreatment with phorone or the carcinogens mirex and 3-methylcholanthrene significantly decreases GRc binding and nuclear uptake in vivo, as well as diminishes intracellular cytosolic GSH levels."( Phorone (diisopropylidene acetone), a glutathione depletor, decreases rat glucocorticoid receptor binding in vivo.
Chiesa, A; Sunahara, GI, 1992
)
2.05
"Pretreatment with phorone or BSO decreased fetal weight and increased the frequency and severity of oligodactyly induced by 5-FU, as well as the reduction of maternal GSH levels."( Effects of phorone and/or buthionine sulfoximine on teratogenicity of 5-fluorouracil in mice.
Deguchi, T; Mataki, Y; Naya, M; Takahira, H; Yasuda, M, 1990
)
0.99

Toxicity

ExcerptReferenceRelevance
" Four hours following injection of a toxic dose of [ring-14C]dichlobenil (12 mg/kg) the covalent binding in the olfactory mucosa was 26 times higher than that in the liver."( Effects of glutathione-modulating agents on the covalent binding and toxicity of dichlobenil in the mouse olfactory mucosa.
Brandt, I; Brittebo, EB; Eriksson, C, 1992
)
0.28
" These toxic effects of ethanol were significantly enhanced in livers, the glutathione content of which had been depleted by pretreatment with phorone."( Enhancement by glutathione depletion of ethanol-induced acute hepatotoxicity in vitro and in vivo.
Pentz, R; Strubelt, O; Younes, M, 1987
)
0.47
" Furthermore, (+)-catechin seems capable of protecting against the direct toxic effect of halothane metabolites resulting from the reductive pathways."( Halothane hepatotoxicity in glutathione depleted rats.
Sellin, D; Siegers, CP; Wilhelm, KP; Younes, M, 1987
)
0.27
" Acetaminophen appeared to be less toxic to selenium-deficient hepatocytes than to controls."( Toxicity studies in isolated hepatocytes from selenium-deficient rats and vitamin E-deficient rats.
Burk, RF; Hill, KE, 1984
)
0.27
" Studies have shown that the formation of toxic metabolites can result from glutathione (GSH) conjugation of toxicants in the liver."( Profile of procarbazine-induced embryotoxicity in an embryo hepatocyte co-culture system and after in utero glutathione depletion.
Andrews, JE; Ebron-McCoy, MT; Kavlock, RJ; Nichols, HP, 1995
)
0.29

Dosage Studied

Phorone reduced biliary excretion of harmol sulfate while increasing the biliaryexcretion ofharmol glucuronide. There was no quantitative relationship between these two parameters based on our phorone dose-response and the carcinogen pretreatment data.

ExcerptRelevanceReference
"Twenty-four hours following injection of a single dose of the herbicide dichlobenil (2,6-dichlorobenzonitrile) in C57Bl/6 mice a steep dose-response curve for the histopathological toxicity in the olfactory mucosa was observed."( Effects of glutathione-modulating agents on the covalent binding and toxicity of dichlobenil in the mouse olfactory mucosa.
Brandt, I; Brittebo, EB; Eriksson, C, 1992
)
0.28
" Although a temporal relationship between the GSH levels and the GRc maximum binding concentrations in vivo was observed, there was no quantitative relationship between these two parameters based on our phorone dose-response and the carcinogen pretreatment data."( Phorone (diisopropylidene acetone), a glutathione depletor, decreases rat glucocorticoid receptor binding in vivo.
Chiesa, A; Sunahara, GI, 1992
)
1.91
" with 250 mg/kg of phorone, a GSH depleting agent and/or 200 mg/kg of buthionine sulfoximine (BSO, an inhibitor of GSH biosynthesis) 4 hours before dosing with 5-FU."( Effects of phorone and/or buthionine sulfoximine on teratogenicity of 5-fluorouracil in mice.
Deguchi, T; Mataki, Y; Naya, M; Takahira, H; Yasuda, M, 1990
)
1
" HCHO (50 mg/kg) increased hepatic metallothionein as early as 8 hr after dosing with maximal levels (27-fold increase) occurring at 72 hr."( Acute exposure to formaldehyde induces hepatic metallothionein synthesis in mice.
Goering, PL, 1989
)
0.28
" At the higher dosage of harmol, phorone reduced the biliary excretion of harmol sulfate while increasing the biliary excretion of harmol glucuronide."( Effect of glutathione depletion on sulfate activation and sulfate ester formation in rats.
Gregus, Z; Howell, S; Klaassen, CD; White, C, 1988
)
0.56
" Animals treated with phorone exhibited decreases in lung glutathione concentration two hours after dosing and increases in lung glutathione concentration 24 hours after dosing."( Glutathione concentrations in rat lung bronchoalveolar lavage fluid: effects of hyperoxia.
Black, RD; Jenkinson, SG; Lawrence, RA, 1988
)
0.59
" To test whether inhibition of protein synthesis was related to GSH depletion, groups of animals were dosed with the alpha, beta-unsaturated carbonyl phorone (diisopropylidenacetone) or the specific inhibitor of GSH synthesis, buthionine sulfoximine (BSO)."( Effect of diethylmaleate and other glutathione depletors on protein synthesis.
Costa, LG; Murphy, SD, 1986
)
0.47
" Therefore, in a second set of experiments, rat embryos were cultured in serum from rats pretreated with two GSH depleters (phorone and buthionine sulfoximine) and subsequently dosed with PCZ."( Profile of procarbazine-induced embryotoxicity in an embryo hepatocyte co-culture system and after in utero glutathione depletion.
Andrews, JE; Ebron-McCoy, MT; Kavlock, RJ; Nichols, HP, 1995
)
0.5
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dialkenyl ketoneAny ketone in which the carbonyl group is bonded to two alkenyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.02710.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency6.81020.000714.592883.7951AID1259369
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency61.09840.003041.611522,387.1992AID1159552; AID1159555
activating transcription factor 6Homo sapiens (human)Potency4.33370.143427.612159.8106AID1159516
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (117)

TimeframeStudies, This Drug (%)All Drugs %
pre-199051 (43.59)18.7374
1990's49 (41.88)18.2507
2000's12 (10.26)29.6817
2010's5 (4.27)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.56 (24.57)
Research Supply Index4.79 (2.92)
Research Growth Index4.17 (4.65)
Search Engine Demand Index81.11 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.68%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other117 (98.32%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]